Speakers

Canada
(Canada)
Dr. Andrew Demchuk

Professor in the Departments of Clinical Neurosciences, Radiology and Heart & Stroke Foundation

Dr. Andrew Demchuk

Dr. Demchuk is a Professor in the Departments of Clinical Neurosciences and Radiology and Heart and Stroke Foundation Chair in Stroke Research. He is also Director of the Calgary Stroke Program. His other roles include Deputy Department Head, Department of Clinical Neurosciences; Deputy Chair, Canadian Stroke Consortium and Co-chair Acute stroke and TIA Working Group in the Cardiovascular Health and Stroke, Strategic Clinical Network, Alberta Health Services where he leads system change initiatives for the province of Alberta.

Dr. Demchuk was co-PI of the ESCAPE trial published in NEJM in 2015 and is a co-PI for the current ENDO-LOW trial evaluating endovascular treatment in patients with mild stroke and a large vessel occlusion. Dr. Demchuk was/is core imaging laboratory lead PI for several prior and current stroke clinical trials such as IMS-3, SPOTLIGHT, CLOTBUST-ER, and ANNEXA-4.

Dr. Demchuk’s research interest is in the area of stroke imaging where he is trying to develop imaging tools/techniques to optimize patient selection for new stroke treatments. Some of these imaging tools have been integrated into major stroke clinical trials to address stroke’s severe heterogeneity. His favorite pursuit however is the training of stroke fellows. The Calgary Stroke Fellowship Program has trained over 90 fellows from 18 countries including 25 now practicing across Canada.

United States of America
(USA)
Dr. Andrew Lee

Professor of Ophthalmology, Neurology and Neurosurgery

Dr. Andrew Lee

Andrew G. Lee, M.D. is chair of the Blanton Eye Institute, Department of Ophthalmology at Houston Methodist Hospital (HMH) in Houston, Texas. He is a Professor of Ophthalmology, Neurology, and Neurosurgery at Weill Cornell Medical College. He additionally carries appointments as Adjunct Professor of Ophthalmology at the University of Iowa and at Baylor College of Medicine; and Clinical Professor at The University of Texas Medical Branch (UTMB) in Galveston, Texas, and The University of Texas MD Anderson Cancer Center (UTMDACC). He is the Program Associate Director of the newly (2014) integrated UTMB/HMH ophthalmology residency program.

Dr. Lee has served on the national and international Editorial Board of over 20 journals including the American Journal of Ophthalmology, JAMA Ophthalmology, the Japanese Journal of Ophthalmology, the Journal of Neuro-ophthalmology, and Eye. He is the Editor in Chief of the Journal of Clinical and Academic Ophthalmology. In 2011 he was named by Becker’s ASC Review as one of the 135 leading ophthalmologists in America and was included in the US News and World Report’s list of Top Doctors. He was awarded the Senior Achievement Award and the Secretariat Award (twice) by the American Academy of Ophthalmology. He has also received the teaching award seven times at five different academic institutions.

Dr. Lee has published over 400 peer-reviewed publications, 40 book chapters, and nine full textbooks in ophthalmology. He has been the invited speaker at over 5oo national and international eye meetings and has delivered 14 named lectures.

United States of America
(USA)
Dr. Edward Cupler

Consultant Neurologist and Neuromuscular Diseases Specialist

Dr. Edward Cupler

Dr. Edward J. Cupler is a Consultant Neurologist and Neuromuscular Diseases Specialist at King Faisal Specialist Hospital & Research Center, Jeddah, Saudi Arabia. Dr. Cupler completed his undergraduate work and medical school at the Ohio State University College of Medicine in 1988. He performed an Internal Medicine internship at Loyola University in Chicago and Neurology residency at Baylor College of Medicine in Houston, followed by a Neuromuscular Disease Fellowship at the National Institute of Health. In 1996 he joined King Faisal Specialist Hospital in Riyadh, Saudi Arabia. During that time Dr. Cupler was active in clinical neurology, post-graduate education and research. Prior to his current position, Dr. Cupler was Associate Professor, Director of the Neuromuscular Disease Center, Neuromuscular Medicine Fellowship Program, and MDA Clinic, and Co-Director of the ALS Center of Oregon at Oregon Health & Science University in Portland. He returned to Saudi Arabia in 2010. Dr. Cupler has shown consistent goals at educating Saudi physicians in neurological sciences and creating research locally.

Dr. Cupler is a member of various organisations and societies and has authored multiple academic publications, book chapters, web-based educational activities and abstracts. He is an investigator on multiple clinical trials.

United States of America
(USA)
Dr. Gregory Krauss

Professor of Neurology and leading epileptologist

Dr. Gregory Krauss

Dr. Gregory Krauss is a Professor of Neurology at Johns Hopkin University and is a leading epileptologist. He helped develop many recently released antiseizure drugs, screens potential anticonvulsants with photosensitivity, is an expert on drug safety, generic drug formulation quality, epilepsy surgery, driving risks with epilepsy, epilepsy care in developing countries and is the inventor of a seizure detector on the Apple Watch called EpiWatch.

United Kingdom
(UK)
Dr. Martin Duddy

Clinical Director for Neurosciences

Dr. Martin Duddy

Dr. Martin Duddy studied biochemistry and medicine at Queen’s University Belfast. His clinical training and postgraduate research in neurology was at the Royal Victoria Hospital, Belfast and the Montreal Neurological Institute, Canada. He was appointed a consultant neurologist with a special interest in MS at the Royal Victoria Infirmary Tyne in 2003 and is currently Clinical Director for Neurosciences. He was clinical lead for the UK MS Risk Sharing Scheme. He is Vice-Chair of the UK MS Society’s MS Registers Management Board and remains active in national and international collaborative studies in MS.

United States of America
(USA)
Dr. Michael Geschwind

Professor of Neurology

Dr. Michael Geschwind

Short Biodata

Dr. Michael D. Geschwind is a Professor of Neurology at the UCSF Memory and Aging Center who specializes in the assessment, treatment and management of rapidly progressive dementias, including prion diseases such as Jakob-Creutzfeldt disease (JCD or CJD) and autoimmune encephalopathies, and other cognitive/movement disorder syndromes. He helped establish a program for the assessment of rapidly progressive dementias (RPDs) at UCSF Medical Center, the first of its kind in the country. He has also helped establish and co-directs a clinic for patients with autoimmune encephalopathies. He co-directs the Huntington’s Disease Society of America Center of Excellence (HDSA COE) and Ataxia clinic at the UCSF Memory and Aging Center. His research interests include rapidly progressive dementias, cognitive dysfunction in movement disorders, such as Huntington's disease, spinocerebellar ataxia, corticobasal degeneration (CBD), progressive supranuclear palsy (PSP) and other Parkinsonian dementias, and CADASIL.

Geschwind earned his MD and PhD in neuroscience through the Medical Scientist Training Program, sponsored by the National Institutes of Health, at the Albert Einstein College of Medicine in New York. He completed an internship in internal medicine at UCLA Medical Center, a neurology residency at the Johns Hopkins University School of Medicine in Baltimore and a fellowship in behavioral neurology at the UCSF Memory and Aging Center. He is a professor of neurology and holds the Michael J. Homer Chair in Neurology in the UCSF School of Medicine.

United Kingdom
(UK)
Dr. Peter Goadsby

Professor of Neurology

Dr. Peter Goadsby

Peter Goadsby obtained his basic medical degree and training at the University of New South Wales, Australia. Neurology training was done with Prof James W. Lance and clinical neurophysiology with Prof David Burke in Sydney. After post‐doctoral work in New York with Don Reis at Cornell, with Jacques Seylaz at Universite VII, Paris, and post‐graduate neurology training at Queen Square, London with Professors C David Marsden, Andrew Lees, Anita Harding and W Ian McDonald, he returned to the University of New South Wales, and the Prince of Wales Hospital, Sydney as a consultant neurologist and was promoted to Associate Professor of Neurology. He was appointed a Wellcome Senior Research Fellow at the Institute of Neurology, University College London in 1995. He was Professor of Clinical Neurology and Honorary Consultant Neurologist at the National Hospital for Neurology and Neurosurgery, Queen Square, London until 2007.

He has been Professor of Neurology, Department of Neurology, University of California, San Francisco since 2007. He has been an Honorary Consultant Neurologist at the Hospital for Sick Children, Great Ormond St, London since 1998. In 2013 he was appointed Director, NIHR‐Wellcome Trust King’s Clinical Research Facility, King’s College Hospital, Professor of Neurology at King’s College London and Honorary Consultant Neurologist, King’s College Hospital.

His major research interests are in the basic mechanisms of primary headache disorders, such as migraine and cluster headache, in both experimental and clinical settings, and translating these insights into their better management.

France
(France)
Dr. Philip Damier

Professor of Neurology, University of Nantes

Dr. Philip Damier

Philippe Damier attended the University of Grenoble in France and, after completing his undergraduate studies in Biological Sciences, graduated from the Medical School in 1989. He was resident in Neurology at the University of Paris VI Pitié-Salpêtrière. He obtained a thesis in Neurosciences (PhD) in 1994 and spent a year as a postdoctoral fellow in Ann Graybiel’s lab (Boston, MA). Philippe became an assistant professor in Pitié-Salpêtrière hospital in 1995, before heading the Clinical Research Center in 1997 (under Yves Agid’s chair).

In 1999, he was appointed as a full professor of Neurology at the University of Nantes. Amongst Professor Damier’s responsibilities at the Medical School, University Hospital of Nantes, he chaired both the Department of Neurology and the Clinical Research Center. He is currently in charge of the expert center in Parkinson’s disease for the West part of France and president of scientific committee of the French Parkinson patient association.

He has published more than 200 scientific articles in international journals, most of them in the field of Parkinson’s disease and movement disorders.

In 2011, he got a Master in Business Administration in Melbourne (Australia). He published two books about managerial decision (2014, 2017).

India
(India)
Dr. Ravindra Kumar Garg

Professor and Head Department of Neurology

Dr. Ravindra Kumar Garg

Dr. Ravindra Kumar Garg is presently working in the Department of Neurology of King George Medical University as Professor and Head. He is having teaching and research experience of 30 years. His areas of interest is CNS infections, CNS tuberculosis, neurocysticercosis, SSPE, Japanese encephalitis, and leprosy. He is section editor of Epilepsy subsection of BMC Neurology. He edited many books on Tropical Neurology, one recently published by Springer.

Kuwait
(Kuwait)
Dr. Raed Al Roughani

Head of MS Clinic

Dr. Raed Al Roughani

Dr. Raed Alroughani received his degree in medicine (MD) from Charles University. He underwent his neurology residency at the University of British Columbia and subsequently obtained the neurology certification from the Royal College of Physicians & Surgeon (Canada). He then completed a fellowship in demyelinating disorders at the University of British Columbia. He joined the division of neurology at Amiri hospital as a consultant neurologist. He currently serves as a head of MS clinic at Ibn-Sina hospital & Amiri Hospitals in Kuwait.

Dr Alroughani’s fields of interest are principally directed towards the epidemiology and therapeutics of multiple sclerosis. He established the national MS registry and the multidisciplinary MS clinic in Kuwait. He is actively involved in research and he authored and co-authored more than 90 papers. His major research interests are epidemiology and therapeutics. Dr Alroughani was awarded the National Prize for scientific production in the field of medical science in 2017.

He is currently the secretary general of MENACTRIMS (Middle East North Africa Committee for the Treatment and Research in Multiple Sclerosis). He is the vice president of the Scientific Leadership Group of MSBase Foundation and an executive board member of ParadigMS Foundation. He currently sits on the executive boards of various scientific associations, steering committees and advisory boards, mainly in the field of MS.